Galldiks, Norbert ORCID: 0000-0002-2485-1796, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Albert, Nathalie L., Chamberlain, Marc, Soffietti, Riccardo, Kim, Michelle M., Law, Ian, Le Rhun, Emilie, Chang, Susan, Schwarting, Julian, Combs, Stephanie E., Preusser, Matthias, Forsyth, Peter, Pope, Whitney ORCID: 0000-0003-4803-1992, Weller, Michael and Tonn, Joerg C. (2019). PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro-Oncology, 21 (5). S. 584 - 596. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Full text not available from this repository.

Abstract

Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Galldiks, NorbertUNSPECIFIEDorcid.org/0000-0002-2485-1796UNSPECIFIED
Langen, Karl-JosefUNSPECIFIEDorcid.org/0000-0003-1101-5075UNSPECIFIED
Albert, Nathalie L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chamberlain, MarcUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Soffietti, RiccardoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kim, Michelle M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Law, IanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Le Rhun, EmilieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chang, SusanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schwarting, JulianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Combs, Stephanie E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Preusser, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Forsyth, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pope, WhitneyUNSPECIFIEDorcid.org/0000-0003-4803-1992UNSPECIFIED
Weller, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tonn, Joerg C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-148865
DOI: 10.1093/neuonc/noz003
Journal or Publication Title: Neuro-Oncology
Volume: 21
Number: 5
Page Range: S. 584 - 596
Date: 2019
Publisher: OXFORD UNIV PRESS INC
Place of Publication: CARY
ISSN: 1523-5866
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
AMINO-ACID PET; POSITRON-EMISSION-TOMOGRAPHY; DYNAMIC F-18-FET PET; LUNG-CANCER PATIENTS; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; RESPONSE ASSESSMENT; FDG-PET; RADIATION NECROSIS; SOLID TUMORS; STEREOTACTIC RADIOSURGERYMultiple languages
Oncology; Clinical NeurologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/14886

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item